Role of CXCL9/CXCR3 Chemokine Biology during Pathogenesis of Acute Lung Allograft Rejection 1
暂无分享,去创建一个
M. Burdick | R. Strieter | J. Belperio | M. Keane | J. Lynch | Y. Xue | D. Zisman | A. Ardehali | D. Ross | Kewang Li | D. Ross
[1] H. Date,et al. [Lung transplantation]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.
[2] J. Squifflet,et al. A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients1 , 2003, Transplantation.
[3] R. Colvin,et al. Further Analysis of the T‐Cell Subsets and Pathways of Murine Cardiac Allograft Rejection , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] 三浦 正義. Monokine induced by IFN-γ is a dominant factor directing T cells into murine cardiac allografts during acute rejection , 2003 .
[5] M. Burdick,et al. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. , 2002, The Journal of clinical investigation.
[6] M. Fishbein,et al. The role of MIG/CXCL9 in cardiac allograft vasculopathy. , 2002, The American journal of pathology.
[7] M. Burdick,et al. Critical Role for CXCR3 Chemokine Biology in the Pathogenesis of Bronchiolitis Obliterans Syndrome1 , 2002, The Journal of Immunology.
[8] M. Burdick,et al. Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients. , 2002, Transplantation.
[9] Z. Aalamian. Reducing adverse effects of immunosuppressive agents in kidney transplant recipients. , 2001, Progress in transplantation.
[10] M. Kasper,et al. Anti-proliferative properties of the phosphodiesterase-4 inhibitor rolipram can supplement immunosuppressive effects of cyclosporine for treatment of obliterative bronchiolitis in heterotopic rat allografts. , 2001, The Journal of Heart and Lung Transplantation.
[11] I. S. Dunn,et al. Tracking membrane and secretory immunoglobulin α heavy chain mRNA variation during B‐cell differentiation by real‐time quantitative polymerase chain reaction , 2001, Immunology and cell biology.
[12] J. Squifflet,et al. INDUCTION VERSUS NONINDUCTION IN RENAL TRANSPLANT RECIPIENTS WITH TACROLIMUS-BASED IMMUNOSUPPRESSION1 , 2001, Transplantation.
[13] M. Burdick,et al. Monokine Induced by IFN-γ Is a Dominant Factor Directing T Cells into Murine Cardiac Allografts During Acute Rejection1 , 2001, The Journal of Immunology.
[14] D. Remick,et al. Early Chemokine Cascades in Murine Cardiac Grafts Regulate T Cell Recruitment and Progression of Acute Allograft Rejection1 , 2001, The Journal of Immunology.
[15] F. Rea,et al. Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. , 2001, The American journal of pathology.
[16] H. Reichenspurner,et al. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[17] T. Strom,et al. ADJUNCTIVE RAPAMYCIN AND CsA TREATMENT INHIBITS MONOCYTE/MACROPHAGE ASSOCIATED CYTOKINES/CHEMOKINES IN SENSITIZED CARDIAC GRAFT RECIPIENTS1 , 2001, Transplantation.
[18] A. Luster,et al. Donor-Derived Ip-10 Initiates Development of Acute Allograft Rejection , 2001, The Journal of experimental medicine.
[19] C. Weber,et al. A Non-peptide Functional Antagonist of the CCR1 Chemokine Receptor Is Effective in Rat Heart Transplant Rejection* , 2001, The Journal of Biological Chemistry.
[20] W. Hancock,et al. Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection , 2000, The Journal of experimental medicine.
[21] R. Gill,et al. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. , 2000, The Journal of clinical investigation.
[22] M. Burdick,et al. The Role of the CC Chemokine, RANTES, in Acute Lung Allograft Rejection1 , 2000, The Journal of Immunology.
[23] C. Tannenbaum,et al. Intraallograft Chemokine RNA and Protein During Rejection of MHC-Matched/Multiple Minor Histocompatibility-Disparate Skin Grafts1 , 2000, The Journal of Immunology.
[24] H. Sarau,et al. Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke. , 2000, Molecular pharmacology.
[25] G. Berry,et al. Successful treatment of acute, ongoing rat lung allograft rejection with the novel immunosuppressant SDZ-RAD. , 2000, The Annals of thoracic surgery.
[26] A. Novick,et al. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig. , 1999, Journal of immunology.
[27] J. Gaynor,et al. Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study. , 1999, Chest.
[28] M. Burdick,et al. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. , 1999, Journal of immunology.
[29] R. Rabin,et al. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. , 1999, Journal of immunology.
[30] A. J. Chandrasekhar,et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. , 1999, American journal of respiratory and critical care medicine.
[31] James G. Boyd,et al. Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3 , 1998, The Journal of experimental medicine.
[32] Arthur S Slutsky,et al. Adenovirus-mediated interleukin-10 gene transfer inhibits post-transplant fibrous airway obliteration in an animal model of bronchiolitis obliterans. , 1998, Human gene therapy.
[33] C. Mackay,et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.
[34] E. Edwards,et al. Antilymphocyte induction therapy in cadaver renal transplantation: a retrospective, multicenter United Network for Organ Sharing Study. , 1997, Transplantation.
[35] P. Halloran,et al. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. , 1997, Transplantation.
[36] Simon A. Jones,et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.
[37] Strieter,et al. Characterization of Chemokine Function in Animal Models of Diseases , 1996, Methods.
[38] G. Berry,et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[39] D. Han,et al. Analysis of interleukin-2 receptor expression in heart-lung transplanted mice. , 1994, Transplantation proceedings.
[40] M. Suthanthiran,et al. Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth. , 1994, Transplantation.
[41] C. Mackay,et al. Homing of naive, memory and effector lymphocytes. , 1993, Current opinion in immunology.
[42] D. Taub,et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells , 1993, The Journal of experimental medicine.
[43] R. Strieter,et al. The bimodal expression of tumor necrosis factor-alpha in association with rat lung reimplantation and allograft rejection. , 1993, Journal of immunology.
[44] R. Strieter,et al. Lung allograft rejection: role of tumor necrosis factor-alpha and interleukin-6. , 1993, Chest.
[45] R. Strieter,et al. Expression of interleukin-6 in association with rat lung reimplantation and allograft rejection. , 1993, The American review of respiratory disease.
[46] N. Sigal,et al. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. , 1992, Annual review of immunology.
[47] M. Burdick,et al. The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. , 1992, Immunological investigations.
[48] M. Suthanthiran,et al. Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction , 1991, The Journal of experimental medicine.
[49] A. Petersen,et al. Diagnosis of rejection in rat lung allografts by bronchoalveolar lavage. , 1987, Transplantation proceedings.
[50] E. Robin,et al. Lung immunogenicity, rejection, and obliterative bronchiolitis. , 1987, Chest.
[51] P. Nieuwenhuis,et al. LUNG ALLOGRAFT REJECTION IN THE RAT: I. ACCELERATED REJECTION CAUSED BY GRAFT LYMPHOCYTES , 1985, Transplantation.
[52] J. Crapo,et al. Reimplantation response in isografted rat lungs. Analysis of causal factors. , 1984, The Journal of thoracic and cardiovascular surgery.
[53] J. Prop. Lung allograft rejection in the rat , 1984 .
[54] C. Wildevuur,et al. Lung transplantation in the rat: I. Technique and survival. , 1982, The Annals of thoracic surgery.
[55] J. C. Norman,et al. Lung transplantation in the rat. , 1971, Transplantation proceedings.